enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Roche joins race for obesity drugs with $2.7 billion Carmot deal

    www.aol.com/news/roche-enters-obesity-drug...

    Roche agreed to take over obesity drug developer Carmot Therapeutics for $2.7 billion, joining a list global contestants seeking to challenge the dominant makers of weight-loss drugs Novo Nordisk ...

  3. Roche shares knocked by concern over side effects in obesity ...

    www.aol.com/news/roche-shares-drop-side-effects...

    Side effects data that Roche released on Monday on another early Carmot project, injection CT-388, had also weighed on its shares, for a 5.4% decline so far this week.

  4. These High-Yield Dividend Stocks Are Turning to Acquisitions ...

    www.aol.com/high-yield-dividend-stocks-turning...

    A wave of mergers and acquisitions (M&A) activity has washed over the oil patch in the last year. Big oil behemoth ExxonMobil kicked things off with its $60 billion deal for Pioneer Natural Resources.

  5. Roche - Wikipedia

    en.wikipedia.org/wiki/Roche

    Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights (a pool of family shareholders 45%, and Maja Oeri a further 5% apart), with Swiss pharma firm Novartis owning a further third of its shares until 2021 ...

  6. Dividend recapitalization - Wikipedia

    en.wikipedia.org/wiki/Dividend_recapitalization

    A dividend recapitalization (often referred to as a dividend recap) in finance is a type of leveraged recapitalization in which a payment is made to shareholders. As opposed to a typical dividend which is paid regularly from the company's earnings, a dividend recapitalization occurs when a company raises debt —e.g. by issuing bonds to fund ...

  7. List of largest pharmaceutical mergers and acquisitions

    en.wikipedia.org/wiki/List_of_largest...

    Valeant raised its unsolicited offer for Allergan a second time, to $53.3 billion, increasing the cash portion of the bid in an effort to win the backing of the company, with the cash-and-stock portion of the bid valuing each Allergan share at $179.25.

  8. Roche open to big acquisitions 'if it makes scientific and ...

    www.aol.com/news/roche-open-big-acquisitions...

    Roche is open to making big acquisitions if they make "sense", Chief Executive Thomas Schinecker said, with the Swiss drugmaker unencumbered by its $20.7 billion deal last year to buy back its ...

  9. Corporate action - Wikipedia

    en.wikipedia.org/wiki/Corporate_action

    Examples of corporate actions include stock splits, dividends, mergers and acquisitions, rights issues, and spin-offs. [ 1 ] Some corporate actions such as a dividend (for equity securities) or coupon payment (for debt securities) may have a direct financial impact on the shareholders or bondholders; another example is a call (early redemption ...